Paediatric Service for Hepatology, Gastroenterology and Nutrition, King's College Hospital, Denmark Hill, SE5 9RS, London UK; Pediatric Intermediate Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via della Commenda 9, 20122 Milan Italy.
Paediatric Service for Hepatology, Gastroenterology and Nutrition, King's College Hospital, Denmark Hill, SE5 9RS, London UK.
Dig Liver Dis. 2021 Jan;53(1):86-93. doi: 10.1016/j.dld.2020.04.017. Epub 2020 Jun 4.
Glycogen storage diseases (GSD) type VI and IX are caused by liver phosphorylase system deficiencies and the two types are clinically indistinguishable.
As the role of liver biopsy is increasingly questioned, we aim to assess its current value in clinical practice.
We retrospectively reviewed children with diagnosis of GSD VI and IX at a paediatric liver centre between 2001 and 2018. Clinical features, molecular analysis and imaging were reviewed. Liver histology was reassessed by a single histopatologist.
Twenty-two cases were identified (9 type VI, 9 IXa, 1 IXb and 3 IXc). Features at presentation were hepatomegaly (95%), deranged AST (81%), short stature (50%) and failure to thrive (4%). Liver biopsy was performed in 19 patients. Fibrosis varied in GSD IXa with METAVIR score between F1-F3 and ISHAK score of F2-F5. METAVIR score was F2-F3 in GSD VI and F3-F4 in GSD IXc. Hepatocyte glycogenation, mild steatosis, lobular inflammatory activity and periportal copper binding protein staining were also demonstrated.
Although GSD VI and IX are considered clinically mild, chronic histological changes of varying severity could be seen in all liver biopsies. Histopathological assessment of the liver involvement is superior to biochemical parameters, but definitive classification requires a mutational analysis.
糖原贮积病(GSD)VI 型和 IX 型是由肝磷酸化酶系统缺乏引起的,两种类型在临床上无法区分。
由于肝活检的作用越来越受到质疑,我们旨在评估其在临床实践中的当前价值。
我们回顾性分析了 2001 年至 2018 年间在儿科肝脏中心诊断为 GSD VI 和 IX 的儿童。回顾了临床特征、分子分析和影像学检查。由一名病理学家重新评估肝脏组织学。
共确定了 22 例病例(9 例 GSD VI、9 例 GSD IXa、1 例 GSD IXb 和 3 例 GSD IXc)。临床表现为肝肿大(95%)、AST 异常(81%)、身材矮小(50%)和生长不良(4%)。19 例患者进行了肝活检。GSD IXa 的纤维化程度在 METAVIR 评分 1-3 级和 ISHAK 评分 2-5 级之间,GSD VI 的 METAVIR 评分为 2-3 级,GSD IXc 的 METAVIR 评分为 3-4 级。还显示了肝细胞糖原沉积、轻度脂肪变性、小叶炎症活动和门管区铜结合蛋白染色。
尽管 GSD VI 和 IX 被认为是临床轻度疾病,但所有肝活检均可见不同严重程度的慢性组织学变化。肝脏受累的组织病理学评估优于生化参数,但明确的分类需要进行突变分析。